Summary The c-fgr protooncogene is a member of the c-src family of tyrosine kinases. Expression of c-fgr was studied in a series of Epstein-Barr virus (EBV) negative Burkitt's lymphoma cell lines and their EBVconverted derivatives. Two transcripts, of 2.9kb and 3.5kb, were present at dramatically elevated levels following EBV-conversion.
A variety of agents, including antigens, lymphokines and mitogens, can activate small resting B-lymphocytes to proliferate and progress to a terminally differentiated state. The molecular mechanisms whereby signals at the B-lymphocyte cell surface generate changes in DNA and RNA synthesis are of considerable interest. B-lymphocyte activation is accompanied by the appearance of a range of cell surface molecules, such as CD23 and Blast-I (Swendeman & Thorley-Lawson, 1987) , and it is probable that some of these activation markers represent receptors for growth and differentiation factors. It has been shown, for example, that a fragment of CD23 shed from the surface of activated Blymphocytes can act as an autocrine B cell growth factor for normal and transformed B-lymphocytes (Swendeman & Thorley-Lawson, 1987) .
Within the cell, a number of changes which may be involved in signalling have been described. These include increases in phosphatidylinositol 4,5-bisphosphate hydrolysis, intracellular free Ca2 + and protein kinase C activation (Ransom et al., 1986) . It is likely that a range of other intracellular molecules are also involved in signalling during B-lymphocyte activation. One candidate is the cellular protooncogene c-fgr, which is a member of a family of genes encoding intracellular proteins with tyrosine kinase activity . Transcripts of c-fgr are induced in B-lymphocytes immortalised by Epstein-Barr virus (EBV) and in EBV-negative Burkitt's lymphoma (BL) cell lines converted with EBV in vitro (Cheah et al., 1986) . Both of these events bear many features in common with B- lymphocyte activation (Thorley-Lawson & Mann, 1985) , involving changes in growth properties (Zeuthen, 1983) and in the expression of B-lymphocyte cell surface activation markers (Rowe et al., 1986) . Cheah et al. (1986) showed that EBV converts of the EBV-negative BL cell lines Ramos and BJAB contained a 3 kb transcript homologous to the cellular proto-oncogene c-fgr, which was undetectable in Ramos and BJAB themselves. Ramos and BJAB and their converts are longestablished cell lines, and have had the opportunity to accumulate phenotypic changes unrelated to their initial EBV conversion. We have therefore studied changes in c-fgr expression in a series of recently established EBV-negative BL cell lines (Calender et al., 1987) , freshly converted with the B95-8 strain of EBV. These cell lines have been well characterised with respect to the pattern of EBV gene expression within them (Murray et al., 1988) , to their growth properties and to the B-lymphocyte activation markers which they express (Rowe et al., 1986; Calender et al., 1987) . We also report here the isolation and sequencing of c-fgr cDNA clones, a necessary first step in the characterisation of the structure of the c-fgr protein and of its function in Blymphocyte activation, and in the mapping of the c-fgr gene for studies of its regulation during B-lymphocyte activation. We describe features of the 5' untranslated region and the 5' coding region of c-fgr mRNA, and demonstrate that the 3' untranslated region contains alternative polyadenylation sites.
Materials and methods
Cell lines EBV-negative BL cell lines IARC BL2, IARC BL31 and IARC BL41, and their EBV-converted sublines IARC BL2-B95/1, IARC BL31-B95/1 and IARC BL41-B95/1, were a gift from Prof. A.B. Rickinson, Cancer Research Campaign Laboratories, Department of Cancer Studies, The Medical School, Birmingham. They were maintained in RPMI 1640 medium supplemented with 15% (v/v) foetal calf serum (Sera-Lab) and 2mM L-glutamine.
RNA preparation
Total RNA was purified from washed cell pellets using the guanidinium isothiocyanate method of Chirgwin et al. (1979) . Polyadenylated RNA was isolated by affinity chromatography on oligo-dT cellulose (Collaborative Research Ltd.) according to Craig et al. (1976) .
Northern blotting
Polyadenylated RNA (2 jg per track) was electrophoresed on a 1% (w/v) agarose MOPS-formaldehyde gel and blotted on to Biodyne membrane (PALL) essentially as described by Taylor et al. (1984) . Filters were probed overnight at 65°C with 32P-labelled antisense RNA, prepared as described below, in hybridisation buffer (60% (v/v) formamide, 5 x SSC, 5 x Denhardt's solution, 20mM sodium phosphate pH 6.8, 1% (w/v) SDS, 7% (w/v) dextran sulphate, 100 jg ml-1 single-stranded sonicated herring testis DNA, 100ugml-l E. coli tRNA, 10 jug ml-1 poly A). Final washes were performed at 65°C in 0.1 x SCC/1% (w/v) SDS. labelled antisense RNA synthesised from Sma I-linearised pFBS2 DNA. Lanes e, f, i and j are lanes c, d, g and h, respectively, reprobed with the 32P-labelled mouse actin cDNA clone pAM91 (Humphries et al., 1981) Watson & Jackson (1985) . The ligated molecules were packaged in vitro and the resultant bacteriophage particles plated out according to Huynh et al. (1985) , yielding a cDNA library of 2 x 105 pfu.
The RPMI 4265 cDNA library was constructed in Agt 10 by Clontech Laboratories Inc. (California) from polyadenylated RNA isolated from the EBV-positive lymphoblastoid cell line RPMI 4265, and was a gift from Dr P. Beverley, ICRF Human Tumour Immunology Unit, University College, London.
Isolation of c-fgr cDNA clones
The cDNA libraries were plated at high density and screened according to Benton & Davis (1977) . The hybridisation probe was pFBS2 DNA, radiolabelled with 32P-dCTP by the oligonucleotide method of Feinberg & Vogelstein (1984) . Hybridisation was performed at 65°C in 6 x SSC containing S x Denhardt's solution and 0.1% (w/v) SDS. Final washes were performed at 65°C in 2 x SSC containing 1% (w/v) SDS.
DNA sequencing Single stranded templates were prepared from Bluescript SK M 13' sub-clones and dideoxy-sequencing was performed using modified T7 DNA polymerase (Sequenase; United States Biochemical Corporation, Ohio). Sequences were analysed with the aid of the Beckman MicroGenie sequence analysis programme (Queen & Korn, 1984) . Oligonucleotides used as sequencing primers, whether homologous to vector or insert sequences, were kindly synthesised for us by Dr Len Hall, Department of Biochemistry, University of Bristol. , that low levels of the 2.9 and 3.5kb c-fgr transcripts are present in BL2, BL31 and BL41 cells, but that there is significant induction upon EBV-conversion. Reprobing of blots with a 32P-labelled actin probe (Figure 1 , lanes e, f, i and j) demonstrated that the polyadenylated RNA in each lane was intact and present in equal quantities, confirming that the induction of c-fgr transcripts upon EBV-conversion is a real phenomenon.
Isolation and nucleotide sequencing of c-fgr cDNA clones In order to determine the relationship of the 2.9kb and 3.5 kb transcripts to each other and to derive information about the 5' end of the c-fgr coding region, we screened two cDNA libraries for c-fgr cDNA clones. Ten positively-hybridising recombinant phage were found amongst 120,000 colonies screened. These were plaque purified, and their inserts were excised with Eco RI and subcloned into the Eco RI site of the plasmid vector Bluescript SK M13+. Restriction maps of the inserts of the three longest clones (pFal, pFcl l & pFd97), each from the RPMI 4265 cDNA library, are shown in Figure 2 . Together, the three clones span 2,347bp and the restriction maps of their central regions are colinear with previously published partial restriction maps of the c-fgr transcript, predicted from the sequences of genomic clones (Parker et al., 1985; Nishizawa et al., 1986) .
Single stranded templates were prepared from pFal, pFa4
(insert of pFAI cloned in the opposite orientation), pFcll and pFd97 and dideoxy-sequencing was performed. Sequences from regions of overlap with previously published genomic sequences (Parker et al., 1985; Nishizawa et al., 1986 ) exhibited 100% homology (data not shown). The sequence of the 5' end of the c-fgr mRNA, derived from clones pFd97 and pFa4, is shown in Figure 3 contain downstream termination codons, and the reading frame indicated is in phase with previously predicted aminoacid sequence . In addition, this initiation codon obeys the rules of Kozak (1987) . Taking these sequence data with those of Nishizawa et al. (1986) , the c-fgr protein would contain 529 amino-acids and would have a predicted molecular weight of -58,000. As shown in Figure 4 , the N-terminal 75 amino-acids of the predicted cfgr protein have low homology with the N-termini of the predicted human lyn, hck, fyn, c-src and c-yes proteins. In contrast, our data and previously published sequence indicate strong homology between these proteins from amino- Figure 4 Optimal alignment of N-terminal 174 amino-acids of predicted c-fgr protein with predicted N-terminal amino-acid sequences of human lyn , hek (Quintrell et al., 1987) , fyn , c-src (Tanaka et al., 1987) and c-yes (Sukegawa et al., 1987) proteins. Percentage homologies with amino-acids 1-75 and 76-529 of the predicted cfgr protein are shown. Amino-acids 175-529 of the c-fgr protein are taken from Nishizawa et al. (1986) and Parker et al. (1985) . Chicken c-src sequences are taken from Tanaka & Hanafusa (1983) . Only residues which are not identical to those in the predicted c-fgr protein are shown. Gaps (-) have been introduced in order to optimise alignments. acid 76 in the predicted c-fgr protein to the carboxyl terminus.
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Differential polyadenylation of c-fgr mRNA As shown in Figure 5 , the cDNA clone pFcl 1 is 271 bp shorter than pFal at the 3' end, and contains there a stretch of 60 adenosine residues. Polyadenylation at this site could be directed by the sequence UAUAAA encoded by nucleotides 2054-2059. Polyadenylation could also be directed downstream by the sequence AGUAAA encoded at nucleotides 2335-2340 in pFal. It is possible that the use of alternative polyadenylation sites accounts for the difference in size between the 2.9kb and the 3.5kb c-fgr transcripts. In order to determine whether this is so, radiolabelled antisense RNA synthesised using the plasmid pF3.4 as a template was used to probe a Northern blot of polyadenylated RNA from Raji and BL2-B95/1 cells. The filter was washed at 80°C in 0.1 x SSC/l % SDS. Hybrids between the 9 bp sequence shared by the probe and the RNA species corresponding to pFcl 1 would not be stable under these conditions. As shown in Figure 6 , the probe hybridised to the 2.9 kb transcript of Raji cells (lane a) and to both the 2.9 kb and 3.5 kb transcripts of BL2-B95/1 cells (lane b). Thus, the downstream polyadenylation site is used in transcripts of both sizes, and use of the upstream site presumably contributes to the apparent heterogeneity of the 2.9 kb RNA (Figure 1,  lanes d, h and k) .
Discussion
We have shown here that in vitro conversion of three recently-established EBV-negative BL cell lines with the B95.8 strain of EBV results in a dramatic elevation of levels of two c-fgr transcripts, of 2.9kb and 3.5 kb. A similar pattern of transcripts has been described in the human Blymphocyte cell line IM-9, derived by in vitro infection of normal peripheral blood B-lymphocytes with EBV (Inoue et al., 1987) . Cheah et al. (1986) were unable to find c-fgr transcripts in the EBV-negative BL cell lines which they studied, but we find that low levels are detectable in the EBV-negative parent cell lines BL2, BL31 and BL41. Many of the changes in cellular phenotype which accompany EBVconversion resemble changes seen during normal Blymphocyte activation, most strikingly the acquisition of cell surface markers such as CD23 and Blast-I (Swendeman & Thorley-Lawson, 1987) . These results raise the possibility, therefore, that the c-fgr protein is involved in the pathway of normal B-lymphocyte activation, perhaps as part of a protein phosphorylation cascade which transduces signals leading to B-lymphocyte differentiation and proliferation.
Transcripts of the c-fgr gene are not limited to Blymphocytes, though, having also been detected in welldifferentiated monocytic cells (Willman et al., 1987) in lung (Tronick et al., 1985) and in placenta . It is not known which cell type(s) express c-fgr in the latter two tissues, but expression may be a reflection of their haematopoietic component.
The c-fgr gene is a member of a family which also includes c-src (Tanaka et al., 1987) , fyn , hck (Quintrell et al., 1987) , Ick (Voronova & Sefton, 1986) , tyn , c-tkl (Strebhardt et al., 1987) and c-yes (Sukegawa et al., 1987) . Unlike other tyrosine kinases such as c-erb-B and c-fms these proteins do not appear to be cell surface receptors, since they are thought to be located at the cytoplasmic surface of the plasma membrane (Pellman et al., 1985) . The c-fgr gene resembles fyn, hck, tck, tyn and c-tkl in having a restricted expression pattern, in contrast to c-src and c-yes whose expression is more widespread.
The proteins encoded by this gene family all have a highly conserved carboxyl-terminal domain which encodes tyrosine kinase activity by analogy with pp6Oc-src. The amino-terminal domains are quite diverged, however, and nucleotide sequence data presented here shows that the amino-terminal domain of the c-fgr protein is also quite different from those of the other members of the family. This sequence divergence may indicate that the various family members, expressed in different cell types, have different substrate specificities. It is unlikely that it engenders differences in intracellular location since all members of the family, including the predicted c-fgr protein, as shown here, retain a glycine residue at position two. In pp6Oc-src this residue is the target for posttranslational myristylation, which is necessary for the localisation of the protein to the inner surface of cytoplasmic membranes (Pellman et al., 1985) . It is likely, then, that the c-fgr protein shares the same intracellular location as pp6Ocsrc. It is also noteworthy that against the general background of diversity in amino-terminal sequences, the predicted tyn, hck, and fyn proteins (but not c-src or c-yes) contain peptides with homology to the sequence Tyr-GlyPro-Asp-Pro-Thr-Lys found at positions 34-40 in the predicted c-fgr protein (Figure 4 ). In addition, the fyn protein has homology to the sequfence Ile-Pro-Asn-Tyr-SerAsn-Phe found at positions [50] [51] [52] [53] [54] [55] [56] [57] (Figures 2 and 3) , is identical to that reported by Inoue et al. (1987) , starting 3 bp downstream of their sequence. However, both our sequence and that of Inoue et al. (1987) differ in the 5' untranslated region from that reported by Katamine et al. (1988) . This latter sequence was derived from a cDNA clone representing an incompletely processed c-fgr transcript containing intron 2.
It is therefore likely that the sequence of the 5' untranslated region reported by Katamine et al. (1988) is in fact derived from intron 1, and that the sequence shown in Figure 3 is that of the 5' untranslated region of the mature mRNA.
The 5' untranslated regions of the mRNAs encoding different members of the tyrosine kinase family may have a role in regulating their differential expression. Marth et al. (1988) have recently shown that the 5' untranslated region of lck mRNA contains AUG codons which reduce the efficiency of translation from the authentic initiation codon. As shown here, the 5' untranslated region of the c-fgr mRNA contains two AUG codons, both of which are outof-frame with respect to the initiating AUG. One of these, at nucleotides 101-103, obeys the rules of Kozak (1987) and so could be recognised by the 40S mammalian ribosomal subunit and be used to initiate translation, masking the authentic AUG. Kozak (1987) (Proudfoot & Brownlee, 1976) , but UAUAAA, a sequence which has also been found to be used as a polyadenylation signal in the gene encoding hepatitis B virus surface antigen (McLauchlan et al., 1985) . The c-fgr cDNA clones of Inoue et al. (1987) and Katamine et al. (1988) have the extended 3' end of pFal, and the data of Katamine et al. (1988) show that the RNA species from which their cDNA clones derive are polyadenylated 13bp downstream of the 3' end of pFal, presumably using the non-consensus polyadenylation signal AGUAAA encoded at nucleotides 2335-2340. This sequence is also used as a polyadenylation signal in the genomes of baboon erythroblastosis virus and mouse mammary tumour virus (McLauchlan et al., 1985) . The sequence AAUAAG encoded at nucleotides 2331-2336 is probably nonfunctional, since it has been shown not to direct polyadenylation of transcripts of a mutant a2-globin gene in a case of ax-thalassaemia (Higgs et al., 1983) . On the basis of the numbers of cDNA clones of each type isolated, the downstream polyadenylation site appears to be used most frequently, Alternative polyadenylation does not account for the size difference between the 2.9kb and 3.5kb c-fgr transcripts but probably contributes to heterogeneity in the lower molecular weight band on Northern blots. This result agrees with recent data from Katamine et al. (1988) , which suggests that the 3.5 kb transcript is an incompletely processed precursor, containing intron 2 of the c-fgr gene. Several genes have been characterised which contain alternative polyadenylation sites. In some cases, such as the bovine and human kininogen genes (Kitamura et al., 1985) and the immunoglobulin iu heavy chain gene (Rogers et al., 1980) , the use of alternative polyadenylation sites generates proteins with different carboxyl-termini. In the case of the immunoglobulin ,u heavy chain gene, polyadenylation site selection is developmentally regulated. The c-fgr gene resembles the rat disulphide isomerase gene (Edman et al., 1985) and the hamster HMG CoA reductase gene (Reynolds et al., 1984) , however, in which the choice of polyadenylation site does not affect the protein product. It is not clear whether the choice of polyadenylation sites in the case of c-fgr is regulated. If it were, it could influence the stability of c-fgr mRNA in different cell types and thus be a mechanism for regulation of c-fgr gene expression. Finally, the availability to us of cDNA clones representing 5' sequences of the c-fgr mRNA now allows us to map the limits of the c-fgr transcription unit in cosmid genomic clones (our unpublished data), in order to study the basis of the regulation of c-fgr gene expression during EBVconversion, and B-lymphocyte activation. In addition, the predicted amino-acid sequence of divergent portions of the cfgr protein allows the synthesis of peptides for production of specific antisera with which to study the expression and function of this protein during the activation of B-lymphocytes.
